Detalhe da pesquisa
1.
Partially CD3+-Depleted Unrelated and Haploidentical Donor Peripheral Stem Cell Transplantation Has Favorable Graft-versus-Host Disease and Survival Rates in Pediatric Hematologic Malignancy.
Biol Blood Marrow Transplant
; 26(3): 493-501, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31765697
2.
Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center.
Cytotherapy
; 20(3): 394-406, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29287970
3.
Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases.
Biol Blood Marrow Transplant
; 23(9): 1463-1472, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28602891
4.
Hydroxyethyl starch as a substitute for dextran 40 for thawing peripheral blood progenitor cell products.
Cytotherapy
; 17(12): 1813-9, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26454752
5.
Training practices of cell processing laboratory staff: analysis of a survey by the Alliance for Harmonization of Cellular Therapy Accreditation.
Cytotherapy
; 17(12): 1831-44, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26455277
6.
Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303.
Biol Blood Marrow Transplant
; 18(5): 690-7, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21875505
7.
Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303.
Biol Blood Marrow Transplant
; 17(9): 1343-51, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21320619
8.
Generation of cytotoxic T-cell lines using overlapping pentadecapeptides derived from conserved regions of the adenovirus hexon protein.
J Gen Virol
; 91(Pt 6): 1577-89, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20130135
9.
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial.
Nat Med
; 26(10): 1569-1575, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33020647
10.
Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation.
J Clin Oncol
; 30(26): 3194-201, 2012 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22869882
11.
Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry.
Arch Pathol Lab Med
; 133(10): 1594-9, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19792049
12.
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.
Blood
; 105(12): 4878-84, 2005 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15731175
13.
Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts.
Blood
; 99(3): 806-14, 2002 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11806980